We Do Well by Doing Good

Len looks back on building Regeneron through decades of setbacks, and on how an ethical, patient-first approach and a founder’s long-term commitment have guided the company from the start.

Leonard S. Schleifer, MD, PhD

Founder, President and Chief Executive Officer

Christina reflects on why earning trust starts with action, helping ensure Regeneron's words, science and priorities align with the needs of patients and communities.

Christina Chan

Senior Vice President, Corporate Affairs

Jon explains how curiosity, patience and a desire to create a better future for the next generation inspire his work to develop genetic medicines.

Jonathon Whitton, AuD, PhD

Vice President, Global Program Head, Genetic Medicines

Chiedza describes how her childhood inspired a passion for science, community and healthcare access that continues to shape her work today.

Chiedza Kaitano, PhD

Vice President, Global Program Head, Obesity

Linnea shares how corporate responsibility brings together what's good for society and good for business, helping turn purpose into action.

Linnea Texin

Executive Director, Corporate Responsibility

Lynda traces her path from molecular biology to patent law and shares why teamwork, mentorship and joy outside of work help her support Regeneron’s mission.

Lynda Nguyen, PhD

Executive Director, Assistant General Counsel

Israel explains why following the science, learning from setbacks and doing the right thing for patients continue to drive his work.

Israel Lowy, MD, PhD

Senior Vice President, Clinical Development Unit Head, Oncology

Michelle shares how losing her mother to breast cancer shaped a lifelong determination to seek answers, challenge convention and pursue what is right for patients and families.

Michelle Alladin

Executive Director, Commercial Immunology Marketing